# HealthTech Capital

> HealthTech Capital is a VC fund backing Health Care and Medical Device. See 98 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Los Altos Hills, United States
- Total investments: 98
- Last investment: Jul 2025
- Lead investor: 10%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/healthtech-capital/
- X (Twitter): http://twitter.com/HealthTechCap
- Website: http://www.healthtechcapital.com
- Facebook: http://www.facebook.com/pages/HealthTech-Capital/221892537834738

HealthTech Capital is a group of private investors dedicated to funding and mentoring new "HealthTech" start ups at the intersection of healthcare with the computer and mobility worlds. HealthTech Capital is creating a new ecosystem with leading edge clinical providers, venture firms and other strategic industry players.

## Contacts

5 contacts available for HealthTech Capital. Shizune tracks 4 team members at HealthTech Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/healthtech-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1M–$3.4M |
| Series A | $1.7M–$16M |
| Convertible Note | $1.3M–$2.5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 47 | 48% |
| Medical Device | 20 | 20% |
| Medical | 15 | 15% |
| Wellness | 11 | 11% |
| Biotechnology | 11 | 11% |

58 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 26 | 27% |
| Series A | 23 | 23% |
| Convertible Note | 17 | 17% |
| Series B | 7 | 7% |
| Funding Round | 5 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 59 | 60% |
| Canada | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Anne DeGheest | Founder & Managing director | 0 | https://shizune.co/investors/profile/anne-degheest |
| Carl Bouthillette | Investor, Member, and Screening Committee Chair | 0 | https://shizune.co/investors/profile/carl-bouthillette |
| Laura Fay | Founding Member | 0 | https://shizune.co/investors/profile/laura-fay |
| Rose Ann Haft | Analyst in Residence | 0 | https://shizune.co/investors/profile/rose-ann-haft |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Journey Live | Journey is a simple meditation practice designed for the modern world, providing on-demand and live-streamed meditation courses.Journey was created to share meditation in a way that all people could relate to, wherever they are in life. It has created a simple yet powerful technique that could appeal to a large-scale audience, changing a lot ofpeople’s lives. It takes a step beyond meditation by introducing six simple yet powerful Life Lessons.Founded in 2015 by Stephen Sokoler, Journey Meditation is headquartered in New York. | $8M | Series A | Jul 25, 2025 |  |
| GT Metabolic Solutions | GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery. | $17.1M | Series B | Mar 12, 2024 |  |
| S2 Genomics | S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomicanalyses.S2 Genomics was founded in 2016 and is headquartered in Livermore, CA. | $16M | Series A | Jan 23, 2024 |  |
| xCures | The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, withan AI-based precision oncology platform that tightly integrates cancer research and care.The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives. |  | Convertible Note | Dec 01, 2023 |  |
| ManagingLife | ManagingLife's industry-leading digital health solution, Manage My Pain, helps patients and doctors better measure, monitor, and manage pain. Manage My Pain is a digital pain treatment companion with clinical validation and has one of the largest datasets that includes over 5M patient-reported pain outcomes from over 125,000 users from 130countries. Built into Manage My Pain is Solace, a first-of-its-kind AI companion that delivers real-time, evidence-based pain psychology support - which showed significant improvements in people who interacted with it for just 30 minutes.Manage My Pain is the leading pain app on the market, and has been licensed by hospitals and insurers across North America. Manage My Pain improves patient outcomes, reduces medical spend, and shortens disability claims. |  | Venture - Series Unknown | Nov 01, 2023 |  |
| Junum | Nutrition First! Our mission is to empower clinical nutrition care to improve patient outcomes across core settings using technology and data. |  | Seed | Sep 15, 2023 |  |
| Wavely Diagnostics | Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care. | $1.4M | Seed | Jul 12, 2023 |  |
| Joylux | Joylux is a health and wellness company that specializes in women's health and wellness. The company is committed to finding scientific solutions that are noninvasive, effective, and affordable to help improve all aspects of a woman’s intimate life. The company was founded in 2013 and headquartered in Seattle, Washington. |  | Convertible Note | Jun 01, 2023 |  |
| Sinaptica Therapeutics | Sinaptica Therapeutics is focused on the development of innovative neuromodulation therapies for Alzheimer's Disease. Their flagship technology, the SinaptiStim™ System, represents a personalized approach to treatment, utilizing closed-loop neuromodulation to enhance cognitive functions. This technology is designed to deliver precisionelectromagnetic therapy, targeting specific neural pathways to improve the symptoms associated with Alzheimer's. Currently, the SinaptiStim™ System is for investigational use and has not received approval for clinical use. Sinaptica Therapeutics is actively engaged in research and development to demonstrate the efficacy and safety of their system, aiming to revolutionize the treatment landscape for Alzheimer's Disease. |  | Pre-Seed | Jun 01, 2023 |  |
| Radius XR | The Radius XR is a portable vision diagnostic and patient engagement system that combines medical-grade diagnostics, business management, and patient education tools in a single wearable AR/VR device. |  | Convertible Note | Mar 01, 2023 |  |

10 of 98 investments shown.

## Co-investors
- [Sand Hill Angels](https://shizune.co/investors/profile/sand-hill-angels) — VC Fund, 8 deals together
- [Wealthing VC Club](https://shizune.co/investors/profile/wealthing-vc-club) — VC Fund, 5 deals together
- [Life Science Angels](https://shizune.co/investors/profile/life-science-angels) — VC Fund, 4 deals together
- [Rock Health Capital](https://shizune.co/investors/profile/rock-health) — VC Fund, 4 deals together
- [The Westly Group](https://shizune.co/investors/profile/the-westly-group) — VC Fund, 4 deals together
- [TSVC](https://shizune.co/investors/profile/tsvcap) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Health Care Investors in United States](https://shizune.co/investors/health-care-investors-united-states)
- [Health Care VC Funds in United States](https://shizune.co/investors/health-care-vc-funds-united-states)
- [Health Care Investors](https://shizune.co/investors/health-care-investors)
- [Health Care VC Funds](https://shizune.co/investors/health-care-vc-funds)
- [Medical Device Investors](https://shizune.co/investors/medical-device-investors)
- [Medical Device VC Funds](https://shizune.co/investors/medical-device-vc-funds)

## FAQ

### What does HealthTech Capital invest in?

HealthTech Capital invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series A stage. Most of the 98 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is HealthTech Capital's check size?

HealthTech Capital typically joins rounds of $1M–$3.4M at Seed, $1.7M–$16M at Series A and $1.3M–$2.5M at Convertible Note. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HealthTech Capital participates in.

### How do I contact HealthTech Capital?

Public channels for HealthTech Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at HealthTech Capital?

The team at HealthTech Capital includes Anne DeGheest (Founder & Managing director), Carl Bouthillette (Investor, Member, and Screening Committee Chair) and Laura Fay (Founding Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co